“CONSEQUENCES OF ABRUPT DISCONTINUATION OF ANTI TUBERCULAR THERAPY (ATT) DUE TO ADVERSE DRUG REACTION (ADRS): A TERTIARY HOSPITAL BASED STUDY”. PharmaNexus Bulletin 2, no. 2 (July 8, 2026): 1–5. Accessed August 27, 2026. https://lapinjournals.com/index.php/pnb/article/view/208.